Please select the option that best describes you:

Would you switch to a TNFi if a patient developed squamous cell skin cancer on abatacept after failure of methotrexate for seropositive RA?  

The patient had no prior TNFi exposure and was not on methotrexate while receiving abatacept.



Answer from: at Academic Institution
Sign in or Register to read more

Answer from: at Academic Institution
Comments
at Emory Health
If "the incidence of NMSC was not significantly hi...
at Arthritis Clinic of Central Texas
Yes. The patient developed it after the first 3-4 ...
Sign in or Register to read more